Track SUPN and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
SUPN - Supernus Pharmaceuticals Inc (SUPN) has a earnings per share of $0.21, down 52.3% over the past year.
Latest EPS (Actual)
$0.21
Beat Rate
75.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | $0.28 | $0.21 | Miss | -25.00% |
| Mar 2026 | $0.41 | $0.88 | Beat | +115.15% |
| Nov 2025 | $0.82 | $0.61 | Miss | -25.61% |
| Aug 2025 | $0.47 | $0.91 | Beat | +93.62% |
| May 2025 | $0.37 | $0.44 | Beat | +18.92% |
| Feb 2025 | $0.52 | $0.55 | Beat | +5.44% |
| Nov 2024 | $0.44 | $1.10 | Beat | +150.00% |
| Aug 2024 | $0.39 | $0.67 | Beat | +71.79% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.